Supplementary Figure I: Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma

Hirotsu KE, Rana J, Wang JY, Raghavan SS, Rieger KE, Srinivas S, Fan AC, Kwong BY, Novoa RA, Zaba LC, Clinicopathologic characterization of enfortumab-vedotin associated cutaneous toxicity in patients with urothelial carcinoma, Journal of the American Academy of Dermatology (2021) doi: https://doi.org/10.1016/j.jaad.2020.11.067.广津KE、拉纳J、王JY、拉古万SS、里格尔KE、斯里尼瓦斯S、范AC、邝BY、诺沃亚RA、扎巴LC. 尿路上皮癌患者中恩福妥单抗（enfortumab-vedotin）相关皮肤毒性的临床病理特征. 《美国皮肤病学会杂志》(2021). DOI: https://doi.org/10.1016/j.jaad.2020.11.067.